This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Adamson, I. Y. Articles by Bowden, D. H. Search for Related Content PubMed PubMed Citation Articles by Adamson, I. Y. Articles by Bowden, D. H.

American Journal of Pathology, Vol 96, 531-544, Copyright © 1979 by American Society for Investigative Pathology

REGULAR ARTICLES

Bleomycin-induced injury and metaplasia of alveolar type 2 cells. Relationship of cellular responses to drug presence in the lung

IY Adamson and DH Bowden

Metaplastic epithelial cells are often observed lining alveoli in bleomycin-induced pulmonary fibrosis. The hypothesis that these cellular changes are induced by the direct action of the drug on differentiating Type 2 cells is now examined in a sequential study to correlate the presence of 3H bleomycin in the lung with the pattern of injury and repair of the alveolar epithelium. A single intravenous dose or multiple small intraperitoneal doses induce focal necrosis of Type 1 epithelial cells followed by Type 2 cell regeneration. At the time of maximal deoxyribonucleic acid (DNA) synthesis in these cells, significant amounts of 3H bleomycin are demonstrable in the lung by scintillation counting; and in autoradiographs, the drug appears to concentrate in epithelial cells. Subsequently many abnormal Type 2 cells are seen. Some are binucleate, and others show nuclear disruption. The usual process of differentiation to Type 1 cells does not occur; instead, a variety of epithelial forms are found, including fetal-like tubular structures and ciliated and squamous metaplastic cells. The correlation of epithelial injury and repair with the direct demonstration of bleomycin in the lung indicates that Type 2 cells are susceptible to injury in the division and differentiation phases of the cell cycle and may then produce a variety of inappropriate alveolar lining cells.

This article has been cited by other articles:

				G. Carraro, L. Perin, S. Sedrakyan, S. Giuliani, C. Tiozzo, J. Lee, G. Turcatel, S. P. De Langhe, B. Driscoll, S. Bellusci, et al. Human Amniotic Fluid Stem Cells Can Integrate and Differentiate into Epithelial Lung Lineages Stem Cells, November 1, 2008; 26(11): 2902 - 2911. [Abstract] [Full Text] [PDF]

				A. Serrano-Mollar, M. Nacher, G. Gay-Jordi, D. Closa, A. Xaubet, and O. Bulbena Intratracheal Transplantation of Alveolar Type II Cells Reverses Bleomycin-induced Lung Fibrosis Am. J. Respir. Crit. Care Med., December 15, 2007; 176(12): 1261 - 1268. [Abstract] [Full Text] [PDF]

				D. N. Kotton, A. J. Fabian, and R. C. Mulligan Failure of Bone Marrow to Reconstitute Lung Epithelium Am. J. Respir. Cell Mol. Biol., October 1, 2005; 33(4): 328 - 334. [Abstract] [Full Text] [PDF]

				D. N. Kotton, B. Y. Ma, W. V. Cardoso, E. A. Sanderson, R. S. Summer, M. C. Williams, and A. Fine Bone marrow-derived cells as progenitors of lung alveolar epithelium Development, December 15, 2001; 128(24): 5181 - 5188. [Abstract] [Full Text] [PDF]

				Y.-H. He, M. Wu, M. Kobune, Y. Xu, M. R. Kelley, and W. J. Martin II Expression of Yeast Apurinic/Apyrimidinic Endonuclease (APN1) Protects Lung Epithelial Cells From Bleomycin Toxicity Am. J. Respir. Cell Mol. Biol., December 1, 2001; 25(6): 692 - 698. [Abstract] [Full Text] [PDF]

				A. Mishra, N. A. Doyle, and W. J. Martin II Bleomycin-Mediated Pulmonary Toxicity . Evidence for a p53-Mediated Response Am. J. Respir. Cell Mol. Biol., May 1, 2000; 22(5): 543 - 549. [Abstract] [Full Text]

				H. G. Folkesson, G. Nitenberg, B. L. Oliver, C. Jayr, K. H. Albertine, and M. A. Matthay Upregulation of alveolar epithelial fluid transport after subacute lung injury in rats from bleomycin Am J Physiol Lung Cell Mol Physiol, September 1, 1998; 275(3): L478 - L490. [Abstract] [Full Text] [PDF]